|
Specific Responsibilities:
The Research Bioinformatics team conducts computational analysis of large datasets to support pre-clinical and discovery research projects in Biology. Major roles include sequence alignment, quantification/statistical analysis, interpretation, and visualization of Gilead-generated and publicly available data. The group has expertise with the analysis of a variety of platforms, such as Nanostring, qPCR, RNA-Seq, ChIP-Seq, and microarrays.
This internship will focus on the analysis, interpretation and visualization of high-throughput sequencing data from laboratory models of human disease.
Essential Functions:
Organizing genomic data and analysis results
Implement software pipelines on a high performance computer cluster
Conduct statistical analysis
Assist in creating interactive, web-based reports
Knowledge, Experience & Skills:
Undergraduate students in their 3rd or 4th year from a research university/college or institute
Graduate student enrolled in master or PhD program from a research university/college or institute; including enrollment in Fall Semester after internship
Major in Bioinformatics, Computational Biology, Genomics, Biostatistics, Computer science or related field.
Experience with Linux and R scripting preferred.
Excellent communication skills and a strong work ethic are essential.
Ability to complete 10-12 consecutive weeks between May and September.
Please note, no relocation is available for this position.
If this is not the right move for you now but remain interested in a career at Gilead Sciences please connect with us via our talent community: https://gilead.avature.net/Gilead
About Gilead:
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions.
|
